Homocysteine levels in schizophrenia and affective disorders—focus on cognition

Frontiers in Behavioral Neuroscience

Volumn 8, Issue OCT, 2014, Pages

  Moustafa, Ahmed A ^a   Hewedi, Doaa H ^b   Eissa, Abeer M ^b   Frydecka, Dorota ^c   Misiak, Błażej ^c  

^a WESTERN SYDNEY UNIVERSITY   (Australia)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Bipolar disorder; Brain substrates; Cognition; Depression; Homocysteine; Hyperhomocysteinemia; Schizophrenia

Indexed keywords

HOMOCYSTEINE;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; APOPTOSIS; BIPOLAR DISORDER; BLOOD VESSEL INJURY; COGNITION; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DNA METHYLATION; EPISODIC MEMORY; EXECUTIVE FUNCTION; GENE; GENETIC POLYMORPHISM; HUMAN; INFORMATION PROCESSING; LANGUAGE PROCESSING; MENTAL PERFORMANCE; MTHFR GENE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN INTERACTION; REVIEW; SCHIZOPHRENIA; SPATIAL LEARNING; WORKING MEMORY;

EID: 84907773482     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2014.00343     Document Type: Review

References (136)

1. Alam, Z., Coombes, N., Waring, R. H., Williams, A. C., and Steventon, G. B. (1998). Plasma levels of neuroexcitatory amino acids in patients with migraine or tension headache. J. Neurol. Sci. 156, 102-106. doi: 10.1016/s0022-510x(98)00023-9
2. Alexopoulos, P., Topalidis, S., Irmisch, G., Prehn, K., Jung, S. U., Poppe, K., et al. (2010). Homocysteine and cognitive function in geriatric depression. Neuropsychobiology 61, 97-104. doi: 10.1159/000275821
3. Algaidi, S. A., Christie, L. A., Jenkinson, A. M., Whalley, L., Riedel, G., and Platt, B. (2006). Long-term homocysteine exposure induces alterations in spatial learning, hippocampal signalling and synaptic plasticity. Exp. Neurol. 197, 8-21. doi: 10.1016/j.expneurol.2005.07.003
4. Alpert, J. E., Mischoulon, D., Nierenberg, A. A., and Fava, M. (2000). Nutrition and depression: focus on folate. Nutrition 16, 544-546. doi: 10.1016/s0899-9007(00)00327-0
5. Ayesa-Arriola, R., Pérez-Iglesias, R., Rodríguez-Sánchez, J. M., Mata, I., Gómez-Ruiz, E., García-Unzueta, M., et al. (2012). Homocysteine and cognition in first-episode psychosis patients. Eur. Arch. Psychiatry Clin. Neurosci. 262, 557-564. doi: 10.1007/s00406-012-0302-2
6. Baek, J. H., Bernstein, E. E., and Nierenberg, A. A. (2013). One-carbon metabolism and bipolar disorder. Aust. N Z J. Psychiatry 47, 1013-1018. doi: 10.1177/0004867413502091
7. Behzadi, A. H., Omrani, Z., Chalian, M., Asadi, S., and Ghadiri, M. (2009). Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double-blind randomized controlled trial. Acta Psychiatr. Scand. 120, 441-445. doi: 10.1111/j.1600-0447.2009.01368.x
8. Bicikova, M., Hampl, R., Hill, M., Ripova, D., Mohr, P., and Putz, Z. (2011). Neuro- and immunomodulatory steroids and other biochemical markers in drug-naive schizophrenia patients and the effect of treatment with atypical antipsychotics. Neuro Endocrinol. Lett. 32, 141-147.
9. Bouaziz, N., Ayedi, I., Sidhom, O., Kallel, A., Rafrafi, R., Jomaa, R., et al. (2010). Plasma homocysteine in schizophrenia: determinants and clinical correlations in Tunisian patients free from antipsychotics. Psychiatry Res.179, 24-29. doi: 10.1016/j.psychres.2010.04.008
10. Boyer, L., Richieri, R., Dassa, D., Boucekine, M., Fernandez, J., Vaillant, F., et al. (2013). Association of metabolic syndrome and inflammation with neurocognition in patients with schizophrenia. Psychiatry Res. 210, 381-386. doi: 10.1016/j.psychres.2013.06.020
11. Bressa, G. M. (1994). S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurol. Scand. Suppl. 154, 7-14. doi: 10.1111/j.1600-0404.1994.tb05403.x
12. Bromberg, A., Bersudsky, Y., Levine, J., and Agam, G. (2009). Global leukocyte DNA methylation is not altered in euthymic bipolar patients. J. Affect. Disord. 118, 234-239. doi: 10.1016/j.jad.2009.01.031
13. Bromberg, A., Levine, J., Nemetz, B., Belmaker, R. H., and Agam, G. (2008). No association between global leukocyte DNA methylation and homocysteine levels in schizophrenia patients. Schizophr. Res. 101, 50-57. doi: 10.1016/j.schres.2008.01.009
14. Brown, A. S., Bottiglieri, T., Schaefer, C. A., Quesenberry, C. P. Jr., Liu, L., Bresnahan, M., et al. (2007). Elevated prenatal homocysteine levels as a risk factor for schizophrenia. Arch. Gen. Psychiatry 64, 31-39. doi: 10.1001/archpsyc.64.1.31
15. Budge, M. M., de Jager, C., Hogervorst, E., Smith, A. D., and Oxford Project To Investigate Memory and Ageing (OPTIMA) (2002). Total plasma homocysteine, age, systolic blood pressure and cognitive performance in older people. J. Am. Geriatr. Soc. 50, 2014-2018. doi: 10.1046/j.1532-5415.2002.50614.x
16. Chen, Z., Karaplis, A. C., Ackerman, S. L., Pogribny, I. P., Melnyk, S., Lussier-Cacan, S., et al. (2001). Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum. Mol. Genet. 10, 433-443. doi: 10.1093/hmg/10.5.433
17. Chen, C. S., Kuo, Y. T., Tsai, H. Y., Li, C. W., Lee, C. C., Yen, C. F., et al. (2011). Brain biochemical correlates of the plasma homocysteine level: a proton magnetic resonance spectroscopy study in the elderly subjects. Am. J. Geriatr. Psychiatry 19, 618-626. doi: 10.1097/JGP.0b013e318209ddf1
18. Chiarani, F., Tramontina, J. F., Ceresér, K. M., Kunz, M., Paim, L., Vargas, C. R., et al. (2013). Homocysteine and other markers of cardiovascular risk during a manic episode in patients with bipolar disorder. Rev. Bras. Psiquiatr.35, 157-160. doi: 10.1590/1516-4446-2012-0797
19. Christie, L. A., Riedel, G., Algaidi, S. A., Whalley, L. J., and Platt, B. (2005). Enhanced hippocampal long-term potentiation in rats after chronic exposure to homocysteine. Neurosci. Lett. 373, 119-124. doi: 10.1016/j.neulet.2004.09.072
20. Coppen, A., and Bailey, J. (2000). Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J. Affect. Disord. 60, 121-130. doi: 10.1016/s0165-0327(00)00153-1
21. Coppen, A., Chaudhry, S., and Swade, C. (1986). Folic acid enhances lithium prophylaxis. J. Affect. Disord. 10, 9-13. doi: 10.1016/0165-0327(86)90043-1
22. de Jonge, P., Alonso, J., Stein, D. J., Kiejna, A., Aguilar-Gaxiola, S., Viana, M. C., et al. (2014). Associations between DSM-IV mental disorders and diabetes mellitus: a role for impulse control disorders and depression. Diabetologia57, 699-709. doi: 10.1007/s00125-013-3157-9
23. Delport, D., Schoeman, R., van der Merwe, N., van der Merwe, L., Fisher, L. R., Geiger, D., et al. (2014). Significance of dietary folate intake, homocysteine levels and MTHFR 677 C>T genotyping in South African patients diagnosed with depression: test development for clinical application. Metab. Brain Dis. 29, 377-384. doi: 10.1007/s11011-014-9506-7
24. den Heijer, T., Vermeer, S. E., Clarke, R., Oudkerk, M., Koudstaal, P. J., Hofman, A., et al. (2003). Homocysteine and brain atrophy on MRI of non-demented elderly. Brain 126, 170-175. doi: 10.1093/brain/awg006
25. Dias, V. V., Brissos, S., Cardoso, C., Andreazza, A. C., and Kapczinski, F. (2009). Serum homocysteine levels and cognitive functioning in euthymic bipolar patients. J. Affect. Disord. 113, 285-290. doi: 10.1016/j.jad.2008.05.011
26. Dietrich-Muszalska, A., Malinowska, J., Olas, B., Głowacki, R., Bald, E., Wachowicz, B., et al. (2012). The oxidative stress may be induced by the elevated homocysteine in schizophrenic patients. Neurochem. Res. 37, 1057-1062. doi: 10.1007/s11064-012-0707-3
27. Di Rocco, A., Rogers, J. D., Brown, R., Werner, P., and Bottiglieri, T. (2000). S-Adenosyl-Methionine improves depression in patients with Parkinson's disease in an open-label clinical trial. Mov. Disord. 15, 1225-1229. doi: 10.1002/1531-8257(200011)15:6<1225::aid-mds1025>3.0.co;2-a
28. Dittmann, S., Seemüller, F., Grunze, H. C., Schwarz, M. J., Zach, J., Fast, K., et al. (2008). The impact of homocysteine levels on cognition in euthymic bipolar patients: a cross-sectional study. J. Clin. Psychiatry 69, 899-906. doi: 10.4088/jcp.v69n0603
29. Dittmann, S., Seemüller, F., Schwarz, M. J., Kleindienst, N., Stampfer, R., Zach, J., et al. (2007). Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results. Bipolar Disord. 9, 63-70. doi: 10.1111/j.1399-5618.2007.00412.x
30. Dufouil, C., Alpérovitch, A., Ducros, V., and Tzourio, C. (2003). Homocysteine, white matter hyperintensities and cognition in healthy elderly people. Ann. Neurol. 53, 214-221. doi: 10.1002/ana.10440
31. Ebesunun, M. O., Eruvulobi, H. U., Olagunju, T., and Owoeye, O. A. (2012). Elevated plasma homocysteine in association with decreased vitamin B(12), folate, serotonin, lipids and lipoproteins in depressed patients. Afr. J. Psychiatry (Johannesbg) 15, 25-29. doi: 10.4314/ajpsy.v15i1.3
32. Ebly, E. M., Schaefer, J. P., Campbell, N. R., and Hogan, D. B. (1998). Folate status, vascular disease and cognition in elderly Canadians. Age Ageing 27, 485-491. doi: 10.1093/ageing/27.4.485
33. Ellingrod, V. L., Taylor, S. F., Dalack, G., Grove, T. B., Bly, M. J., Brook, R. D., et al. (2012). Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics. J. Clin. Psychopharmacol. 32, 261-265. doi: 10.1097/JCP.0b013e3182485888
34. Eren, E., Yeğin, A., Yilmaz, N., and Herken, H. (2010). Serum total homocystein, folate and vitamin B12 levels and their correlation with antipsychotic drug doses in adult male patients with chronic schizophrenia. Clin. Lab. 56, 513-518.
35. Faux, N. G., Ellis, K. A., Porter, L., Fowler, C. J., Laws, S. M., Martins, R. N., et al. (2011). Homocysteine, vitamin B12 and folic acid levels in Alzheimer's disease, mild cognitive impairment and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study. J. Alzheimers Dis. 27, 909-922. doi: 10.3233/JAD-2011-110752
36. Fava, M., Borus, J. S., Alpert, J. E., Nierenberg, A. A., Rosenbaum, J. F., and Bottiglieri, T. (1997). Folate, vitamin B12 and homocysteine in major depressive disorder. Am. J. Psychiatry 154, 426-428.
37. Feng, L., Ng, T. P., Chuah, L., Niti, M., and Kua, E. H. (2006). Homocysteine, folate and vitamin B-12 and cognitive performance in older Chinese adults: findings from the Singapore Longitudinal ageing study. Am. J. Clin. Nutr. 84, 1506-1512.
38. Folstein, M., Liu, T., Peter, I., Buell, J., Arsenault, L., Scott, T., et al. (2007). The homocysteine hypothesis of depression. Am. J. Psychiatry 164, 861-867. doi: 10.1176/appi.ajp.164.6.861
39. Ford, A. H., Flicker, L., Singh, U., Hirani, V., and Almeida, O. P. (2013). Homocysteine, depression and cognitive function in older adults. J. Affect. Disord. 151, 646-651. doi: 10.1016/j.jad.2013.07.012
40. Frankenburg, F. R. (2007). The role of one-carbon metabolism in schizophrenia and depression. Harv. Rev. Psychiatry 15, 146-160. doi: 10.1080/10673220701551136
41. Freeman, J. M., Finkelstein, J. D., and Mudd, S. H. (1975). Folate-responsive homocystinuria and "schizophrenia". A defect in methylation due to deficient 5,10-methylenetetrahydrofolate reductase activity. N. Engl. J. Med. 292, 491-496. doi: 10.1056/nejm197503062921001
42. Friso, S., Choi, S. W., Girelli, D., Mason, J. B., Dolnikowski, G. G., Bagley, P. J., et al. (2002). A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Natl. Acad. Sci. U S A 99, 5606-5611. doi: 10.1073/pnas.062066299
43. Gabryelewicz, T., Styczynska, M., Luczywek, E., Barczak, A., Pfeffer, A., Androsiuk, W., et al. (2007). The rate of conversion of mild cognitive impairment to dementia: predictive role of depression. Int. J. Geriatr. Psychiatry 22, 563-567. doi: 10.1002/gps.1716
44. Gao, L., Zeng, X. N., Guo, H. M., Wu, X. M., Chen, H. J., Di, R. K., et al. (2011). Cognitive and neurochemical alterations in hyperhomocysteinemic rat. Neurol. Sci. 33, 39-43. doi: 10.1007/s10072-011-0645-x
45. Garcia, A., Haron, Y., Pulman, K., Hua, L., and Freedman, M. (2004). Increases in homocysteine are related to worsening of stroop scores in healthy elderly persons: a prospective follow-up study. J. Gerontol. A Biol. Sci. Med. Sci. 59, 1323-1327. doi: 10.1093/gerona/59.12.1323
46. García-Bueno, B., Bioque, M., Mac-Dowell, K. S., Barcones, M. F., Martínez-Cengotitabengoa, M., Pina-Camacho, L., et al. (2013). Pro-/Anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia. Schizophr. Bull. 40, 376-387. doi: 10.1093/schbul/sbt001
47. Geller, V., Friger, M., Sela, B. A., and Levine, J. (2013). Elevated homocysteine level in siblings of patients with schizophrenia. Psychiatry Res. 210, 769-772. doi: 10.1016/j.psychres.2013.08.016
48. Genedani, S., Agnati, L. F., Leo, G., Buzzega, D., Maccari, F., Carone, C., et al. (2010). beta-Amyloid fibrillation and/or hyperhomocysteinemia modify striatal patterns of hyaluronic acid and dermatan sulfate: possible role in the pathogenesis of Alzheimer's disease. Curr. Alzheimer Res. 7, 150-157. doi: 10.2174/156720510790691074
49. Gilbody, S., Lewis, S., and Lightfoot, T. (2007). Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am. J. Epidemiol. 165, 1-13. doi: 10.1093/aje/kwj347
50. Goff, D. C., Bottiglieri, T., Arning, E., Shih, V., Freudenreich, O., Evins, A. E., et al. (2004). Folate, homocysteine and negative symptoms in schizophrenia. Am. J. Psychiatry 161, 1705-1708. doi: 10.1176/appi.ajp.161.9.1705
51. Hill, M., Shannahan, K., Jasinski, S., Macklin, E. A., Raeke, L., Roffman, J. L., et al. (2011). Folate supplementation in schizophrenia: a possible role for MTHFR genotype. Schizophr. Res. 127, 41-45. doi: 10.1016/j.schres.2010.12.006
52. Ho, P. I., Ortiz, D., Rogers, E., and Shea, T. B. (2002). Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J. Neurosci. Res. 70, 694-702. doi: 10.1002/jnr.10416
53. Holroyd, C. B., and Coles, M. G. (2002). The neural basis of human error processing: reinforcement learning, dopamine and the error-related negativity. Psychol. Rev. 109, 679-709. doi: 10.1037/0033-295x.109.4.679
54. Hooshmand, B., Solomon, A., Kåreholt, I., Rusanen, M., Hänninen, T., Leiviskä, J., et al. (2012). Associations between serum homocysteine, holotranscobalamin, folate and cognition in the elderly: a longitudinal study. J. Intern. Med. 271, 204-212. doi: 10.1111/j.1365-2796.2011.02484.x
55. Ivorra, J. L., Rivero, O., Costas, J., Iniesta, R., Arrojo, M., Ramos-Ríos, R., et al. (2014). Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case-control sample from Spain. Schizophr. Res. doi: 10.1016/j.schres.2014.07.004. [Epub ahead of print].
56. Jendricko, T., Vidović, A., Grubisić-Ilić, M., Romić, Z., Kovacić, Z., and Kozarić-Kovacić, D. (2009). Homocysteine and serum lipids concentration in male war veterans with posttraumatic stress disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 134-140. doi: 10.1016/j.pnpbp.2008.11.002
57. Johnson, W. G. (1999). DNA polymorphism-diet-cofactor-development hypothesis and the gene-teratogen model for schizophrenia and other developmental disorders. Am. J. Med. Genet. 88, 311-323. doi: 10.1002/(sici)1096-8628(19990820)88:4<311::aid-ajmg6>3.3.co;2-m
58. Kale, A., Naphade, N., Sapkale, S., Kamaraju, M., Pillai, A., Joshi, S., et al. (2010). Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism. Psychiatry Res. 175, 47-53. doi: 10.1016/j.psychres.2009.01.013
59. Kalmijn, S., Launer, L. J., Lindemans, J., Bots, M. L., Hofman, A., and Breteler, M. M. (1999). Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am. J. Epidemiol.150, 283-289. doi: 10.1093/oxfordjournals.aje.a010000
60. Kim, G., Kim, H., Kim, K. N., Son, J. I., Kim, S. Y., Tamura, T., et al. (2013). Relationship of cognitive function with B vitamin status, homocysteine and tissue factor pathway inhibitor in cognitively impaired elderly: a cross-sectional survey. J. Alzheimers Dis. 33, 853-862. doi: 10.3233/JAD-2012-121345
61. Kinoshita, M., Numata, S., Tajima, A., Shimodera, S., Imoto, I., and Ohmori, T. (2013). Plasma total homocysteine is associated with DNA methylation in patients with schizophrenia. Epigenetics 8, 584-590. doi: 10.4161/epi.24621
62. Klancnik, J. M., Cuénod, M., Gähwiler, B. H., Jiang, Z. P., and Do, K. Q. (1992). Release of endogenous amino acids, including homocysteic acid and cysteine sulphinic acid, from rat hippocampal slices evoked by electrical stimulation of Schaffer collateral-commissural fibres. Neuroscience 49, 557-570. doi: 10.1016/0306-4522(92)90226-r
63. Koz, S. T., Gouwy, N. T., Demir, N., Nedzvetsky, V. S., Etem, E., and Baydas, G. (2010). Effects of maternal hyperhomocysteinemia induced by methionine intake on oxidative stress and apoptosis in pup rat brain. Int. J. Dev. Neurosci. 28, 325-329. doi: 10.1016/j.ijdevneu.2010.02.006
64. Kuo, P. H., Chuang, L. C., Liu, J. R., Liu, C. M., Huang, M. C., Lin, S. K., et al. (2014). Identification of novel loci for bipolar I disorder in a multi-stage genome-wide association study. Prog. Neuropsychopharmacol. Biol. Psychiatry51, 58-64. doi: 10.1016/j.pnpbp.2014.01.003
65. Lancon, C., Dassa, D., Fernandez, J., Richieri, R., Padovani, R., and Boyer, L. (2012). Are cardiovascular risk factors associated with verbal learning and memory impairment in patients with schizophrenia? A cross-sectional study. Cardiovasc. Psychiatry Neurol. 2012:204043. doi: 10.1155/2012/204043
66. Lencz, T., Guha, S., Liu, C., Rosenfeld, J., Mukherjee, S., DeRosse, P., et al. (2013). Genome-wide association study implicates NDST3 in schizophrenia and bipolar disorder. Nat. Commun. 4:2739. doi: 10.1038/ncomms3739
67. Levine, J., Stahl, Z., Sela, B. A., Gavendo, S., Ruderman, V., and Belmaker, R. H. (2002). Elevated homocysteine levels in young male patients with schizophrenia. Am. J. Psychiatry 159, 1790-1792. doi: 10.1176/appi.ajp.159.10.1790
68. Levine, J., Timinsky, I., Vishne, T., Dwolatzky, T., Roitman, S., Kaplan, Z., et al. (2008). Elevated serum homocysteine levels in male patients with PTSD. Depress. Anxiety 25, E154-E157. doi: 10.1002/da.20400
69. Lewis, S. J., Zammit, S., Gunnell, D., and Smith, G. D. (2005). A meta-analysis of the MTHFR C677T polymorphism and schizophrenia risk. Am. J. Med. Genet. B Neuropsychiatr. Genet. 135B, 2-4. doi: 10.1002/ajmg.b.30170
70. Li, C., Zhan, G., Rao, S., and Zhang, H. (2014). Metabolic syndrome and its factors affect cognitive function in chronic schizophrenia complicated by metabolic syndrome. J. Nerv. Ment. Dis. 202, 313-318. doi: 10.1097/nmd.0000000000000124
71. Lindenmayer, J. P., Khan, A., Kaushik, S., Thanju, A., Praveen, R., Hoffman, L., et al. (2012). Relationship between metabolic syndrome and cognition in patients with schizophrenia. Schizophr. Res. 142, 171-176. doi: 10.1016/j.schres.2012.09.019
72. Lipton, S. A., Kim, W. K., Choi, Y. B., Kumar, S., D'Emilia, D. M., Rayudu, P. V., et al. (1997). Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. U S A 94, 5923-5928. doi: 10.1073/pnas.94.11.5923
73. Lok, A., Bockting, C. L., Koeter, M. W., Snieder, H., Assies, J., Mocking, R. J., et al. (2013). Interaction between the MTHFR C677T polymorphism and traumatic childhood events predicts depression. Transl. Psychiatry 3:e288. doi: 10.1038/tp.2013.60
74. Lok, A., Mocking, R. J., Assies, J., Koeter, M. W., Bockting, C. L., de Vries, G. J., et al. (2014). The one-carbon-cycle and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in recurrent major depressive disorder; influence of antidepressant use and depressive state? J. Affect. Disord. 166, 115-123. doi: 10.1016/j.jad.2014.04.048
75. Loureiro, S. O., Romão, L., Alves, T., Fonseca, A., Heimfarth, L., Moura Neto, V., et al. (2010). Homocysteine induces cytoskeletal remodeling and production of reactive oxygen species in cultured cortical astrocytes. Brain Res. 1355, 151-164. doi: 10.1016/j.brainres.2010.07.071
76. Lu, M. L., Lin, C. H., Chen, Y. C., Yang, H. C., and Wu, T. H. (2013). Determination of olanzapine and N-desmethyl-olanzapine in plasma using a reversed-phase HPLC coupled with coulochemical detection: correlation of olanzapine or N-desmethyl-olanzapine concentration with metabolic parameters. PLoS One 8:e65719. doi: 10.1371/journal.pone.0065719
77. Lundin, N. B., Niciu, M. J., Luckenbaugh, D. A., Ionescu, D. F., Richards, E. M., Vande Voort, J. L., et al. (2014). Baseline vitamin B12 and folate levels do not predict improvement in depression after a single infusion of ketamine. Pharmacopsychiatry 47, 141-144. doi: 10.1055/s-0034-1377042
78. Macpherson, H., Ellis, K. A., Sali, A., and Pipingas, A. (2012). Memory improvements in elderly women following 16 weeks treatment with a combined multivitamin, mineral and herbal supplement: a randomized controlled trial. Psychopharmacology (Berl) 220, 351-365. doi: 10.1007/s00213-011-2481-3
79. Mangoni, A. A., and Jackson, S. H. (2002). Homocysteine and cardiovascular disease: current evidence and future prospects. Am. J. Med. 112, 556-565. doi: 10.1016/S0002-9343(02)01021-5
80. Matté, C., Pereira, L. O., Dos Santos, T. M., Mackedanz, V., Cunha, A. A., Netto, C. A., et al. (2009). Acute homocysteine administration impairs memory consolidation on inhibitory avoidance task and decreases hippocampal brain-derived neurotrophic factor immunocontent: prevention by folic acid treatment. Neuroscience163, 1039-1045. doi: 10.1016/j.neuroscience.2009.07.023
81. McGuffin, P., Knight, J., Breen, G., Brewster, S., Boyd, P. R., Craddock, N., et al. (2005). Whole genome linkage scan of recurrent depressive disorder from the depression network study. Hum. Mol. Genet. 14, 3337-3345. doi: 10.1093/hmg/ddi363
82. Misiak, B., Frydecka, D., Piotrowski, P., and Kiejna, A. (2013). The multidimensional nature of metabolic syndrome in schizophrenia: lessons from studies of one-carbon metabolism and DNA methylation. Epigenomics 5, 317-329. doi: 10.2217/epi.13.22
83. Misiak, B., Frydecka, D., Slezak, R., Piotrowski, P., and Kiejna, A. (2014). Elevated homocysteine level in first-episode schizophrenia patients-the relevance of family history of schizophrenia and lifetime diagnosis of cannabis abuse. Metab. Brain Dis. 29, 671. doi: 10.1007/s11011-014-9567-7
84. Morris, M. S. (2003). Homocysteine and Alzheimer's disease. Lancet Neurol. 2, 425-428. doi: 10.1016/s1474-4422(03)00438-1
85. Mühleisen, T. W., Leber, M., Schulze, T. G., Strohmaier, J., Degenhardt, F., Treutlein, J., et al. (2014). Genome-wide association study reveals two new risk loci for bipolar disorder. Nat. Commun. 5:3339. doi: 10.1038/ncomms4339
86. Muntjewerff, J. W., Kahn, R. S., Blom, H. J., and den Heijer, M. (2006). Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol. Psychiatry 11, 143-149. doi: 10.1038/sj.mp.4001746
87. Narayan, S. K., Saxby, B. K., Firbank, M. J., O'Brien, J. T., Harrington, F., Mckeith, I. G., et al. (2011). Plasma homocysteine and cognitive decline in older hypertensive subjects. Int. Psychogeriatr. 23, 1607-1615. doi: 10.1017/s1041610211000779
88. Naughton, M., Clarke, G., O'Leary, O. F., Cryan, J. F., and Dinan, T. G. (2014). A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action. J. Affect. Disord. 156, 24-35. doi: 10.1016/j.jad.2013.11.014
89. Nishi, A., Numata, S., Tajima, A., Kinoshita, M., Kikuchi, K., Shimodera, S., et al. (2014). Meta-analyses of blood homocysteine levels for gender and genetic association studies of the MTHFR C677T polymorphism in schizophrenia. Schizophr. Bull. 40, 1154-1163. doi: 10.1093/schbul/sbt154
90. Nurk, E., Refsum, H., Tell, G. S., Engedal, K., Vollset, S. E., Ueland, P. M., et al. (2005). Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study. Ann. Neurol. 58, 847-857. doi: 10.1002/ana.20645
91. Osher, Y., Bersudsky, Y., Silver, H., Sela, B. A., and Belmaker, R. H. (2008). Neuropsychological correlates of homocysteine levels in euthymic bipolar patients. J. Affect. Disord. 105, 229-233. doi: 10.1016/j.jad.2007.04.005
92. Peerbooms, O. L., Van Os, J., Drukker, M., Kenis, G., Hoogveld, L., De Hert, M., et al. (2011). Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability? Brain Behav. Immun. 25, 1530-1543. doi: 10.1016/j.bbi.2010.12.006
93. Penninx, B. W., Guralnik, J. M., Ferrucci, L., Fried, L. P., Allen, R. H., and Stabler, S. P. (2000). Vitamin B(12) deficiency and depression in physically disabled older women: epidemiologic evidence from the Women's Health and Aging Study. Am. J. Psychiatry 157, 715-721. doi: 10.1176/appi.ajp.157.5.715
94. Permoda-Osip, A., Dmitrzak-Weglarz, M., Hauser, J., and Rybakowski, J. K. (2014a). Are genes connected with homocysteine metabolism associated with bipolar disorder? Neuropsychobiology 69, 107-111. doi: 10.1159/000358091
95. Permoda-Osip, A., Dorszewska, J., Bartkowska-Sniatkowska, A., Chlopocka-Wozniak, M., and Rybakowski, J. K. (2013a). Vitamin B12 level may be related to the efficacy of single ketamine infusion in bipolar depression. Pharmacopsychiatry 46, 227-228. doi: 10.1055/s-0033-1349861
96. Permoda-Osip, A., Dorszewska, J., and Rybakowski, J. (2014b). The concentration of homocysteine and treatment of depression in affective disorders. Farmakoter Psychiatr. Neurol. 1, 15-20.
97. Permoda-Osip, A., Dorszewska, J., Skibinska, M., Chlopocka-Wozniak, M., and Rybakowski, J. K. (2013b). Hyperhomocysteinemia in bipolar depression: clinical and biochemical correlates. Neuropsychobiology 68, 193-196. doi: 10.1159/000355292
98. Perna, A. F., Ingrosso, D., and De Santo, N. G. (2003). Homocysteine and oxidative stress. Amino Acids 25, 409-417. doi: 10.1007/s00726-003-0026-8
99. Petronijević, N. D., Radonjić, N. V., Ivković, M. D., Marinković, D., Piperski, V. D., Duricić, B. M., et al. (2008). Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 1921-1926. doi: 10.1016/j.pnpbp.2008.09.009
100. Pirchl, M., Ullrich, C., and Humpel, C. (2010). Differential effects of short- and long-term hyperhomocysteinaemia on cholinergic neurons, spatial memory and microbleedings in vivo in rats. Eur. J. Neurosci. 32, 1516-1527. doi: 10.1111/j.1460-9568.2010.07434.x
101. Prins, N. D., Den Heijer, T., Hofman, A., Koudstaal, P. J., Jolles, J., Clarke, R., et al. (2002). Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology 59, 1375-1380. doi: 10.1212/01.wnl.0000032494.05619.93
102. Rajagopalan, P., Hua, X., Toga, A. W., Jack, C. R. Jr., Weiner, M. W., and Thompson, P. M. (2011). Homocysteine effects on brain volumes mapped in 732 elderly individuals. Neuroreport 22, 391-395. doi: 10.1097/wnr.0b013e328346bf85
103. Regland, B., Johansson, B. V., Grenfeldt, B., Hjelmgren, L. T., and Medhus, M. (1995). Homocysteinemia is a common feature of schizophrenia. J. Neural Transm. Gen. Sect. 100, 165-169. doi: 10.1007/bf01271539
104. Ripke, S., Neale, B. M., Corvin, A., Walters, J. T. R., Farh, K.-H., Holmans, P. A., et al. (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421-427. doi: 10.1038/nature13595
105. Ripke, S., O'dushlaine, C., Chambert, K., Moran, J. L., Kähler, A. K., Akterin, S., et al. (2013). Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 45, 1150-1159. doi: 10.1038/ng.2742
106. Roffman, J. L., Brohawn, D. G., Friedman, J. S., Dyckman, K. A., Thakkar, K. N., Agam, Y., et al. (2011a). MTHFR 677C>T effects on anterior cingulate structure and function during response monitoring in schizophrenia: a preliminary study. Brain Imaging Behav. 5, 65-75. doi: 10.1007/s11682-010-9111-2
107. Roffman, J. L., Gollub, R. L., Calhoun, V. D., Wassink, T. H., Weiss, A. P., Ho, B. C., et al. (2008a). MTHFR 677C -> T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val -> Met. Proc. Natl. Acad. Sci. U S A 105, 17573-17578. doi: 10.1073/pnas.0803727105
108. Roffman, J. L., Lamberti, J. S., Achtyes, E., Macklin, E. A., Galendez, G. C., Raeke, L. H., et al. (2013). Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia. JAMA Psychiatry 70, 481-489. doi: 10.1001/jamapsychiatry.2013.900
109. Roffman, J. L., Nitenson, A. Z., Agam, Y., Isom, M., Friedman, J. S., Dyckman, K. A., et al. (2011b). A hypomethylating variant of MTHFR, 677C>T, blunts the neural response to errors in patients with schizophrenia and healthy individuals. PLoS One 6:e25253. doi: 10.1371/journal.pone.0025253
110. Roffman, J. L., Weiss, A. P., Deckersbach, T., Freudenreich, O., Henderson, D. C., Purcell, S., et al. (2007). Effects of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism on executive function in schizophrenia. Schizophr. Res. 92, 181-188. doi: 10.1016/j.schres.2007.01.003
111. Roffman, J. L., Weiss, A. P., Deckersbach, T., Freudenreich, O., Henderson, D. C., Wong, D. H., et al. (2008b). Interactive effects of COMT Val108/158Met and MTHFR C677T on executive function in schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B, 990-995. doi: 10.1002/ajmg.b.30684
112. Sachdev, P. S., Valenzuela, M., Wang, X. L., Looi, J. C., and Brodaty, H. (2002). Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals. Neurology 58, 1539-1541. doi: 10.1212/wnl.58.10.1539
113. Saito, T., Kondo, K., Iwayama, Y., Shimasaki, A., Aleksic, B., Yamada, K., et al. (2014). Replication and cross-phenotype study based upon schizophrenia GWASs data in the Japanese population: support for association of MHC region with psychosis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 165B, 421-427. doi: 10.1002/ajmg.b.32246
114. Scott, J. M., and Weir, D. G. (1998). Folic acid, homocysteine and one-carbon metabolism: a review of the essential biochemistry. J. Cardiovasc. Risk 5, 223-227. doi: 10.1177/174182679800500403
115. Shen, X., Wu, Y., Guan, T., Wang, X., Qian, M., Lin, M., et al. (2014). Association analysis of COMT/MTHFR polymorphisms and major depressive disorder in Chinese Han population. J. Affect. Disord. 161, 73-78. doi: 10.1016/j.jad.2014.03.008
116. Shi, J., Gershon, E. S., and Liu, C. (2008). Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Schizophr. Res. 104, 96-107. doi: 10.1016/j.schres.2008.06.016
117. Shorvon, S. D., Carney, M. W., Chanarin, I., and Reynolds, E. H. (1980). The neuropsychiatry of megaloblastic anaemia. Br. Med. J. 281, 1036-1038. doi: 10.1136/bmj.281.6247.1036
118. Sklar, P., Ripke, S., Scott, L. J., Andreassen, O. A., Cichon, S., Craddock, N., et al. (2011). Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat. Genet. 43, 977-983. doi: 10.1038/ng.943
119. Stanger, O., Fowler, B., Piertzik, K., Huemer, M., Haschke-Becher, E., Semmler, A., et al. (2009). Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations. Expert Rev. Neurother. 9, 1393-1412. doi: 10.1586/ern.09.75
120. Streck, E. L., Bavaresco, C. S., Netto, C. A., and Wyse, A. T. (2004). Chronic hyperhomocysteinemia provokes a memory deficit in rats in the Morris water maze task. Behav. Brain Res. 153, 377-381. doi: 10.1016/j.bbr.2003.12.013
121. Streck, E. L., Delwing, D., Tagliari, B., Matte, C., Wannmacher, C. M., Wajner, M., et al. (2003). Brain energy metabolism is compromised by the metabolites accumulating in homocystinuria. Neurochem. Int. 43, 597-602. doi: 10.1016/s0197-0186(02)00230-9
122. Tan, H. Y., Callicott, J. H., and Weinberger, D. R. (2007). Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia. Cereb. Cortex 17(Suppl 1), i171-181. doi: 10.1093/cercor/bhm069
123. Teunissen, C. E., Blom, A. H., Van Boxtel, M. P., Bosma, H., De Bruijn, C., Jolles, J., et al. (2003). Homocysteine: a marker for cognitive performance? A longitudinal follow-up study. J. Nutr. Health Aging 7, 153-159.
124. Trimmer, E. E. (2013). Methylenetetrahydrofolate reductase: biochemical characterization and medical significance. Curr. Pharm. Des. 19, 2574-2593. doi: 10.2174/1381612811319140008
125. van den Kommer, T. N., Dik, M. G., Comijs, H. C., Jonker, C., and Deeg, D. J. (2010). Homocysteine and inflammation: predictors of cognitive decline in older persons? Neurobiol. Aging 31, 1700-1709. doi: 10.1016/j.neurobiolaging.2008.09.009
126. Vermeer, S. E., Van Dijk, E. J., Koudstaal, P. J., Oudkerk, M., Hofman, A., Clarke, R., et al. (2002). Homocysteine, silent brain infarcts and white matter lesions: the Rotterdam scan study. Ann. Neurol. 51, 285-289. doi: 10.1002/ana.10111
127. Vuksan-Ćusa, B., Jakovljević, M., Šagud, M., Mihaljević Peleš, A., Marčinko, D., Topić, R., et al. (2011). Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics. Psychiatry Res. 189, 21-25. doi: 10.1016/j.psychres.2010.11.021
128. Vuksan-Ćusa, B., Šagud, M., Jakovljević, M., Peleš, A. M., Jaksic, N., Mihaljević, S., et al. (2013). Association between C-reactive protein and homocysteine with the subcomponents of metabolic syndrome in stable patients with bipolar disorder and schizophrenia. Nord. J. Psychiatry 67, 320-325. doi: 10.3109/08039488.2012.745601
129. Wang, J., Bai, X., Chen, Y., Zhao, Y., and Liu, X. (2012). Homocysteine induces apoptosis of rat hippocampal neurons by inhibiting 14-3-3epsilon expression and activating calcineurin. PLoS One 7:e48247. doi: 10.1371/journal.pone.0048247
130. Wu, Y. L., Ding, X. X., Sun, Y. H., Yang, H. Y., Chen, J., Zhao, X., et al. (2013). Association between MTHFR C677T polymorphism and depression: an updated meta-analysis of 26 studies. Prog. Neuropsychopharmacol. Biol. Psychiatry 46, 78-85. doi: 10.1016/j.pnpbp.2013.06.015
131. Wysokiński, A., and Kłoszewska, I. (2013). Homocysteine levels in patients with schizophrenia on clozapine monotherapy. Neurochem. Res. 38, 2056-2062. doi: 10.1007/s11064-013-1113-1
132. Xu, W., Cohen-Woods, S., Chen, Q., Noor, A., Knight, J., Hosang, G., et al. (2014). Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1. BMC Med. Genet. 15:2. doi: 10.1186/1471-2350-15-2
133. Yapislar, H., Aydogan, S., and Ozüm, Ü. (2012). Biological understanding of the cardiovascular risk associated with major depression and panic disorder is important. Int. J. Psychiatry Clin. Pract. 16, 27-32. doi: 10.3109/13651501.2011.620127
134. Yoshimi, A., Aleksic, B., Kawamura, Y., Takahashi, N., Yamada, S., Usui, H., et al. (2010). Gene-wide association study between the methylenetetrahydrofolate reductase gene (MTHFR) and schizophrenia in the Japanese population, with an updated meta-analysis on currently available data. Schizophr. Res. 124, 216-222. doi: 10.1016/j.schres.2010.07.011
135. Yoshino, K., Nishide, M., Sankai, T., Inagawa, M., Yokota, K., Moriyama, Y., et al. (2010). Validity of brief food frequency questionnaire for estimation of dietary intakes of folate, vitamins B6 and B12 and their associations with plasma homocysteine concentrations. Int. J. Food Sci. Nutr. 61, 61-67. doi: 10.3109/09637480903286363
136. Zhang, D., and Lipton, S. A. (1992). L-homocysteic acid selectively activates N-methyl-D-aspartate receptors of rat retinal ganglion cells. Neurosci. Lett. 139, 173-177. doi: 10.1016/0304-3940(92)90545-i